EN
HI
Goldline Pharmaceutical share price chart
Goldline Pharmaceutical Share Key Metrics
Volume
15000.00
Market Cap
38.87 CR
LTQ@LTP
3000@40.09
ATP
40.85
Var Margin
53.5 %
Circuit Range
32.4-48.58
Delivery %
94.44 %
Value
6.13 L
ASM/GSM
No
Market Lot
3000
Summary
GLPL stock price is ₹40.09 as of 21 Jul, 2026. The stock intraday movement has stayed between ₹40.09 and ₹41.40, while Goldline Pharmaceutical share price 52 week high low is ₹38.25 & ₹60.00.
In terms of trading activity, GLPL share price has recorded a volume of 15,000 shares. The Goldline Pharmaceutical has a market cap of ₹9600000. The stock’s Average Traded Price (ATP) stands at ₹40.85, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3000 @ ₹40.09.
The Goldline Pharmaceutical upper circuit limit is ₹48.58 & The Goldline Pharmaceutical lower circuit limit is ₹32.40, with a Value of ₹6.13 L. The Delivery Percentage for the day is 94.44%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹ 3K.
Goldline Pharmaceutical Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.58
Sector P/B
3.24
Sec. Div. Yield
0.53
Goldline Pharmaceutical Resistance and Support
Pivot 39.83
Resistance
First Resistance
41.41
Second Resistance
42.33
Third Resistance
43.91
Support
First Support
38.91
Second Support
37.33
Third Support
36.41
Goldline Pharmaceutical Corporate Actions
| Date | Agenda |
|---|---|
| 2026-06-09 | Audited Results |
Goldline Pharmaceutical News
Goldline Pharmaceutical Ltd - 544759 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Goldline Pharmaceutical's Promoter and Whole Time Director, Swapan Khandelwal, acquired 60,000 equity shares via open market purchase. This transaction increased his total shareholding by 0.62% to 29.27%.
Jun 24 2026 13:20:06
Goldline Pharmaceutical Ltd - 544759 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Goldline Pharmaceutical's Promoter and Whole Time Director, Mr. Swapan Khandelwal, acquired 60,000 equity shares, raising his stake by 0.62%. This open market purchase brings his total holding to 29.27%.
Jun 24 2026 13:19:00
Read More
Goldline Pharmaceutical Management
| Name | Position |
|---|---|
| Amol Laxmikant Mujumdar | Chairman & Managing Director |
| Swapan Premprakash Khandelwal | Whole Time Director |
Goldline Pharmaceutical Similar Stocks
Goldline Pharmaceutical FAQs
The Buying Price of Goldline Pharmaceutical share is 40.09 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Goldline Pharmaceutical stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Goldline Pharmaceutical, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Goldline Pharmaceutical shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Goldline Pharmaceutical shares is 0. Useful to assess the stock's value relative to its book value.
To assess Goldline Pharmaceutical’s valuation compare Sector P/E, P/B which are 69.58 & 3.24 with sector averages, along with growth rates and financial metrics.
The Market Cap of Goldline Pharmaceutical is 38.87 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Goldline Pharmaceutical share price is 60.00 & 38.25. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Goldline Pharmaceutical belongs to the Healthcare sector.
Open a FREE Demat Account in 5 Mins.
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
